Skip to content

ClearPoint Neuro, Inc.: 10-Q filed 2020-11-12

What ClearPoint Neuro, Inc. reported in its quarterly report filed 2020-11-12 (fiscal Q3 2020): 33 published measures, 93 facts as tagged in accession 0001171520-20-000454.

This filing

Form
10-Q (quarterly report)
Filed
2020-11-12
Fiscal period
fiscal Q3 2020
Accession
0001171520-20-000454 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ClearPoint Neuro, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-3021,846,917USD
At 2019-12-3111,926,437USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-3021,697,817USD
At 2019-12-317,339,720USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-30149,100USD
At 2020-06-301,339,829USD
At 2020-03-312,759,860USD
At 2019-12-314,586,717USD
At 2019-09-306,007,956USD
At 2019-06-306,907,142USD
At 2019-03-31442,619USD
At 2018-12-311,511,002USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-09-3014,665,597USD
At 2019-12-315,695,722USD
At 2019-09-306,235,168USD
At 2018-12-313,101,133USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-1,484,232USD92
2020-01-01 to 2020-09-30-5,200,105USD274
2020-04-01 to 2020-06-30-1,661,048USD91
2020-01-01 to 2020-03-31-2,054,825USD91
2019-07-01 to 2019-09-30-1,122,968USD92
2019-01-01 to 2019-09-30-3,894,088USD273
2019-04-01 to 2019-06-30-1,550,395USD91
2019-01-01 to 2019-03-31-1,220,725USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-5,404,999USD274
2019-01-01 to 2019-12-31-2,849,515USD365
2019-01-01 to 2019-09-30-2,383,705USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-09-3010,190USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2020-07-01 to 2020-09-303,519,187USD92
2020-01-01 to 2020-09-309,112,563USD274
2019-07-01 to 2019-09-302,927,466USD92
2019-01-01 to 2019-09-308,006,382USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-09-3014,816,215USD274
2019-01-01 to 2019-09-305,677,930USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-441,341USD274
2019-01-01 to 2019-09-30-160,190USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-30-117,939,725USD
At 2019-12-31-112,739,620USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-09-30327,055USD
At 2019-12-31447,162USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-09-30762,488USD274
2019-01-01 to 2019-09-30576,012USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-1,271,496USD92
2020-01-01 to 2020-09-30-3,954,654USD274
2019-07-01 to 2019-09-30-910,529USD92
2019-01-01 to 2019-09-30-3,175,896USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-3020,142,459USD
At 2019-12-3110,383,084USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-07-01 to 2020-09-30201,245USD92
2020-01-01 to 2020-09-301,240,091USD274
2019-07-01 to 2019-09-30213,167USD92
2019-01-01 to 2019-09-30726,292USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-303,713,122USD
At 2019-12-313,832,947USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-09-301,064,121USD
At 2019-12-31965,783USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-09-301,449,333USD
At 2019-12-311,089,917USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-09-303,534,643USD
At 2019-12-313,240,218USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2020-07-01 to 2020-09-30718,787USD92
2020-01-01 to 2020-09-302,276,927USD274
2019-07-01 to 2019-09-30983,042USD92
2019-01-01 to 2019-09-302,899,837USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2020-07-01 to 2020-09-301,369,900USD92
2020-01-01 to 2020-09-304,013,493USD274
2019-07-01 to 2019-09-301,029,929USD92
2019-01-01 to 2019-09-302,991,305USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-07-01 to 2020-09-301,209,048USD92
2020-01-01 to 2020-09-302,860,877USD274
2019-07-01 to 2019-09-30761,881USD92
2019-01-01 to 2019-09-302,044,224USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-3015,881,404shares
At 2019-12-3115,235,308shares

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-09-30294,583USD
At 2019-12-31374,218USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2020-09-3017,744,396USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-09-3023,380USD
At 2019-12-3182,573USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-09-30492,886USD
At 2019-12-31357,227USD

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2020-01-01 to 2020-09-30170,057USD274
2019-01-01 to 2019-09-30105,310USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-11,491USD92
2020-01-01 to 2020-09-30-5,360USD274
2019-07-01 to 2019-09-30728USD92
2019-01-01 to 2019-09-308,100USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-01-01 to 2020-09-301,399,182USD274
2019-01-01 to 2019-09-3082,621USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30359,416USD274
2019-01-01 to 2019-09-30895,189USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30323,075USD274
2019-01-01 to 2019-09-30908,413USD273

Inspect the source

Entity
ClearPoint Neuro, Inc. / CIK 0001285550
Captured
2026-09-20T07:49:10.325Z
SEC response SHA-256
42cce1b4fae43ade1c2eab56e81afab6eae0d04e4ec290dc982d64b677ec31fb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001285550.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))